Small molecule FGF receptor inhibitors block FGFR-dependent urothelial carcinoma growth in vitro and in vivo
Fiona R. Lamont, Margaret A. Knowles(St James's University Hospital)
Cited by 178
Related Papers
Intragenic ERBB2 kinase mutations in tumours
|Nature|2004|790
An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer
|Nature Communications|2021|381
Oncogenic FGFR3 gene fusions in bladder cancer
|Human Molecular Genetics|2012|378